Analyst Ratings for EyePoint Pharmaceuticals, Inc. (EYPT)
EYPT Rating Summary
EYPT Price Target Summary
- Highest: $50.00 (Laidlaw)
- Lowest: $33.00 (H.C. Wainwright)
- Average: $41.83
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$41.83 (+154%)
* Over Last 12-Mos
Rating Score: 9.2 / 10
Percentile Rank: 90%
Avg. $ Target:
$41.83 (+154%)
* Over Last 12-Mos
Rating Score: 9.2 / 10
Percentile Rank: 90%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/22/2024 | JPMorgan | Tessa Romero | New Coverage | Overweight (N/A) |
35.00 (N/A) |
22.86 (16.47) |
-27.95% | Details |
| 12/11/2023 | CapitalOne | Zegbah Jallah | New Coverage | Overweight (N/A) |
44.00 (N/A) |
19.15 (16.47) |
-13.99% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
